| Typicality: | 0.450 |
| Saliency: | 0.293 |
| in clinical trials | 5 | location |
| at the same time | 3 | temporal |
| against leishmania | 2 | transitive-object |
| compound → show → promising results | 8 |
| compound → shown → promising results | 5 |
| negative | neutral | positive |
| 0.010 | 0.129 | 0.861 |
| Raw frequency | 13 |
| Normalized frequency | 0.293 |
| Modifier score | 1.000 |
| Perplexity | 238.260 |